Eric Bjerkholt Mirum Pharmaceuticals, Inc. (MIRM) insider trading activity

Eric Bjerkholt is CHIEF FINANCIAL OFFICER of Mirum Pharmaceuticals, Inc.. Currently has a direct ownership of 33,279 shares of MIRM, which is worth approximately $1.38 Million. The most recent transaction as insider was on Nov 08, 2024, when has been sold 475 shares (Common Stock) at a price of $21.05 per share, resulting in proceeds of $9,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.3K

1.45% 3M change

232.79% 12M change

Total Value Held $1.38 Million

ERIC BJERKHOLT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2024	BUY Grant, award, or other acquisition	$9,998 $21.05 p/Share	475 Added 1.41%	33,279 Common Stock
Sep 11 2024	BUY Exercise of conversion of derivative security	-	18,334 Added 35.85%	32,804 Common Stock
May 10 2024	BUY Grant, award, or other acquisition	$9,893 $21.05 p/Share	470 Added 3.15%	14,470 Common Stock
Mar 27 2024	BUY Open market or private purchase	$49,600 $24.8 p/Share	2,000 Added 12.5%	14,000 Common Stock
Mar 18 2024	BUY Open market or private purchase	$51,600 $25.8 p/Share	2,000 Added 14.29%	12,000 Common Stock
Sep 11 2023	BUY Open market or private purchase	$296,500 $29.65 p/Share	10,000 Added 50.0%	10,000 Common Stock

Also insider at

KDNY

CHINOOK THERAPEUTICS, INC. Healthcare

Chief Financial Officer

CERS

CERUS CORP Healthcare

SRZN

Surrozen, Inc. Healthcare

GRAY

GRAYBUG VISION, INC. Healthcare

Eric Bjerkholt

CHIEF FINANCIAL OFFICER

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIRM shares.

Notify only if

Value

Insider Trading

Get notified when an Mirum Pharmaceuticals, Inc. insider buys or sells MIRM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Mirum Pharmaceuticals, Inc.

Track Activities on MIRM

Account